On Monday, HCW Biologics Inc (NASDAQ: HCWB) opened higher 60.82% from the last session, before settling in for the closing price of $3.45. Price fluctuations for HCWB have ranged from $2.77 to $100.80 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -29.55%. Company’s average yearly earnings per share was noted 85.06% at the time writing. With a float of $1.63 million, this company’s outstanding shares have now reached $2.15 million.
Let’s determine the extent of company efficiency that accounts for 36 employees.
HCW Biologics Inc (HCWB) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of HCW Biologics Inc is 24.25%, while institutional ownership is 1.00%. The most recent insider transaction that took place on May 16 ’25, was worth 60,002. In this transaction Chief Executive Officer of this company bought 8,054 shares at a rate of $7.45, taking the stock ownership to the 501,911 shares. Before that another transaction happened on May 16 ’25, when Company’s Director bought 1,342 for $7.45, making the entire transaction worth $9,998. This insider now owns 4,075 shares in total.
HCW Biologics Inc (HCWB) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -4 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -5.2) by 1.2. Wall Street market experts anticipate that the next fiscal year will bring earnings of -2.43 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 85.06% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 55.47% during the next five years compared to -29.55% drop over the previous five years of trading.
HCW Biologics Inc (NASDAQ: HCWB) Trading Performance Indicators
Check out the current performance indicators for HCW Biologics Inc (HCWB). In the past quarter, the stock posted a quick ratio of 0.11. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 14.38.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -16.07, a number that is poised to hit -2.30 in the next quarter and is forecasted to reach -5.01 in one year’s time.
Technical Analysis of HCW Biologics Inc (HCWB)
Looking closely at HCW Biologics Inc (NASDAQ: HCWB), its last 5-days average volume was 17.58 million, which is a jump from its year-to-date volume of 0.91 million. As of the previous 9 days, the stock’s Stochastic %D was 42.63%.
During the past 100 days, HCW Biologics Inc’s (HCWB) raw stochastic average was set at 18.50%, which indicates a significant decrease from 60.70% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.50 in the past 14 days, which was lower than the 0.78 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.37, while its 200-day Moving Average is $11.24. However, in the short run, HCW Biologics Inc’s stock first resistance to watch stands at $6.97. Second resistance stands at $8.38. The third major resistance level sits at $9.42. If the price goes on to break the first support level at $4.52, it is likely to go to the next support level at $3.48. Now, if the price goes above the second support level, the third support stands at $2.07.
HCW Biologics Inc (NASDAQ: HCWB) Key Stats
There are currently 2,152K shares outstanding in the company with a market cap of 11.93 million. Presently, the company’s annual sales total 2,570 K according to its annual income of -30,020 K. Last quarter, the company’s sales amounted to 10 K and its income totaled -2,200 K.
